The suitability of recycled poly(ethylene terephthalate) (R-PET) for 3D-printing applications was evaluated by studying the melt flow characteristics of the polymer. R-PET is known to experience significant deterioration in its mechanical properties when recycled due to molecular weight loss that results from reprocessing. Lower molecular weight hinders R-PET from being 3D-printable due to low viscosity and melt strength. The hypothesis was that R-PET can be modified with reasonable effort and resources to a 3D-printable thermoplastic if the low viscosity problem is tackled. Higher viscosity will enhance both the melt strength and the melt flow characteristic of the polymer, making it more suitable for processing and 3D printing. Reactive extrusion was selected as the method for modifying the polymer to achieve the objective via a coupling reaction with chain extender PMDA (pyromellitic dianhydride). A decrease in the melt flow index (MFI) from 90 to 1.2 (g/10 min) was recorded when PMDA was added at 0.75 wt% which lowered the MFI of modified R-PET to a comparable value to commercial 3D-printing filaments. Furthermore, FT-IR analysis was performed to investigate the chemical composition of the product. Finally, a 3D-printing filament was made from the modified R-PET by mimicking the main processing stations that exist in the filament-making process, which are the extrusion stage, water bath cooling stage and spooling stage. With 0.75 wt% PMDA, the melt strength was satisfactory for pulling the filament and, therefore, a filament with on-spec dimension was produced. Finally, a small object was successfully 3D-printed using the filament product at a minimum recommended temperature of 275 °C.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.